4 June 2020 - Deborah Wilkes
Archived
A clinical trial in the UK is evaluating the efficacy of Infirst’s Flarin as a treatment for certain symptoms experienced by patients hospitalised with COVID-19.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.